scispace - formally typeset
V

Vanesa Muncan

Researcher at University of Amsterdam

Publications -  57
Citations -  3321

Vanesa Muncan is an academic researcher from University of Amsterdam. The author has contributed to research in topics: Intestinal epithelium & Wnt signaling pathway. The author has an hindex of 22, co-authored 52 publications receiving 2881 citations. Previous affiliations of Vanesa Muncan include Royal Netherlands Academy of Arts and Sciences & Academic Medical Center.

Papers
More filters
Journal ArticleDOI

Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector.

TL;DR: A doxycycline‐regulated form of the H1 promoter of RNA polymerase III that allows the inducible knockdown of gene expression by small interfering RNAs (siRNAs) is designed and targeted β‐catenin in colorectal cancer cells as a proof‐of‐principle.
Journal ArticleDOI

Myc deletion rescues Apc deficiency in the small intestine

TL;DR: Loss of Myc rescued the phenotypes of perturbed differentiation, migration, proliferation and apoptosis, which occur on deletion of Apc, and Array analysis revealed that Myc is required for the majority of Wnt target gene activation following Apc loss.
Journal ArticleDOI

Rapid Loss of Intestinal Crypts upon Conditional Deletion of the Wnt/Tcf-4 Target Gene c-Myc

TL;DR: In this article, the role of the proto-oncogene c-Myc in colorectal cancer cell lines was assessed by conditional gene deletion, and it was shown that c-myc−/− crypt cells are on average much smaller than wild-type cells, cycle slower, and divide at a smaller cell size.
Journal ArticleDOI

Focal Adhesion Kinase Is Required for Intestinal Regeneration and Tumorigenesis Downstream of Wnt/c-Myc Signaling

TL;DR: It is shown that the integrin effector protein Focal Adhesion Kinase (FAK) is dispensable for normal intestinal homeostasis and DNA damage signaling, but is essential for intestinal regeneration following DNA damage, and suggests that FAK inhibitors may suppress tumorigenesis in patients at high risk of developing colorectal cancer.